ATE361289T1 - Piperazinsubstituierte arylbenzodiazepine - Google Patents

Piperazinsubstituierte arylbenzodiazepine

Info

Publication number
ATE361289T1
ATE361289T1 AT03784411T AT03784411T ATE361289T1 AT E361289 T1 ATE361289 T1 AT E361289T1 AT 03784411 T AT03784411 T AT 03784411T AT 03784411 T AT03784411 T AT 03784411T AT E361289 T1 ATE361289 T1 AT E361289T1
Authority
AT
Austria
Prior art keywords
sup
sub
alkyl
optionally substituted
hydrogen
Prior art date
Application number
AT03784411T
Other languages
English (en)
Inventor
Thomas Daniel Aicher
Zhaogen Chen
Huerou Yvan Le
Fionna Mitchell Martin
Marta Maria Pineiro-Nunez
Vincent Patrick Rocco
Kevin Michael Ruley
John Mehnert Schaus
Patrick Gianpietro Spinazze
David Edward Tupper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE361289T1 publication Critical patent/ATE361289T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT03784411T 2002-08-05 2003-07-28 Piperazinsubstituierte arylbenzodiazepine ATE361289T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40129702P 2002-08-05 2002-08-05

Publications (1)

Publication Number Publication Date
ATE361289T1 true ATE361289T1 (de) 2007-05-15

Family

ID=31715704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784411T ATE361289T1 (de) 2002-08-05 2003-07-28 Piperazinsubstituierte arylbenzodiazepine

Country Status (10)

Country Link
US (1) US7384934B2 (de)
EP (1) EP1546134B1 (de)
AT (1) ATE361289T1 (de)
AU (1) AU2003264915A1 (de)
CY (1) CY1110382T1 (de)
DE (1) DE60313634T2 (de)
DK (1) DK1546134T3 (de)
ES (1) ES2285227T3 (de)
PT (1) PT1546134E (de)
WO (1) WO2004014895A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1243262T3 (da) 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
ES2185606T3 (es) 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
WO2005026177A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
AR048272A1 (es) * 2004-03-18 2006-04-12 Lek Pharmaceuticals Sintesis de 2 metil - 4- (4- metil -1- piperazinil) - 10 h- tieno ( 2,3-b) (1,5) benzodiazepina y sus sales, metodos para su preparacion, composiciones farmaceuticas que la contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mentales.
PL1781276T3 (pl) 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
EP1642889A1 (de) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Verbessertes Syntheseschema für Lacosamid
MY147756A (en) 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
WO2007144195A2 (en) 2006-06-15 2007-12-21 Schwarz Pharma Ag Pharmaceutical composition with synergistic anticonvulsant effect
AU2008225014B2 (en) 2007-03-15 2014-12-11 Protocell Therapeutics, Inc. Dibenzo(b,f)(1,4)oxazapine compounds
JP2011510960A (ja) * 2008-01-31 2011-04-07 フェルミオン オサケ ユキチュア ケチアピンの製造方法
PL395468A1 (pl) * 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
CN104837838A (zh) 2012-08-21 2015-08-12 詹森药业有限公司 帕潘立酮半抗原
ES2669565T3 (es) 2012-08-21 2018-05-28 Janssen Pharmaceutica Nv Haptenos de risperidona y paliperidona
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
PL2888592T3 (pl) 2012-08-21 2018-03-30 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
PL2888257T3 (pl) 2012-08-21 2018-02-28 Janssen Pharmaceutica Nv Hapteny kwetiapiny do zastosowania w testach immunologicznych
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
JP6131414B2 (ja) 2012-08-21 2017-05-24 ヤンセン ファーマシューティカ エヌ．ベー． アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用
EP2888284B1 (de) 2012-08-21 2022-07-06 Janssen Pharmaceutica NV Antikörper gegen risperidon-haptene und verwendungen davon
JP6450314B2 (ja) 2012-08-21 2019-01-09 ヤンセン ファーマシューティカ エヌ．ベー． クエチアピンハプテンに対する抗体及びその使用
CN104854110B (zh) * 2012-08-21 2016-12-28 詹森药业有限公司 奥氮平半抗原
WO2014031656A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine haptens and use thereof
JP2015527365A (ja) 2012-08-21 2015-09-17 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンに対する抗体及びその使用
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ．ベー． アリピプラゾールハプテンに対する抗体及びその使用
KR101991148B1 (ko) 2012-10-15 2019-06-19 알베마를 코포레이션 2-아미노-4,6-디메톡시벤즈아미드 및 기타 벤즈아미드 화합물의 합성 방법
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
RU2610169C2 (ru) 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" ПРОИЗВОДНЫЕ 7-ФТОРО-8-ХЛОРО-5Н-ДИБЕНЗО[b, е][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ
CN104530077A (zh) * 2014-12-29 2015-04-22 杭州师范大学 一种奥氮平中间体的合成方法
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
EP3390449A1 (de) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antikörper gegen risperidon und verwendung davon
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
RU2667954C2 (ru) 2016-03-04 2018-09-25 Общество С Ограниченной Ответственностью "Валентек" Фармацевтическая композиция для лечения функциональных психических расстройств
CN110452183B (zh) * 2019-09-04 2023-03-14 中国科学院上海有机化学研究所 一种手性杂环化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB8819059D0 (en) * 1988-08-11 1988-09-14 Lilly Industries Ltd Benzodiazepine compounds & their use as pharmaceuticals
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
CN1268949A (zh) * 1997-09-02 2000-10-04 吉富制药株式会社 稠合噻吩化合物及其医药用途
CA2479932A1 (en) * 2002-03-28 2003-10-09 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders

Also Published As

Publication number Publication date
PT1546134E (pt) 2007-08-10
CY1110382T1 (el) 2015-04-29
US20060084643A1 (en) 2006-04-20
DK1546134T3 (da) 2007-09-10
US7384934B2 (en) 2008-06-10
DE60313634T2 (de) 2008-01-31
WO2004014895A1 (en) 2004-02-19
EP1546134A1 (de) 2005-06-29
EP1546134B1 (de) 2007-05-02
AU2003264915A1 (en) 2004-02-25
DE60313634D1 (de) 2007-06-14
ES2285227T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
ATE361289T1 (de) Piperazinsubstituierte arylbenzodiazepine
AU2003217936A1 (en) Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
YU73300A (sh) Biciklični pirimidini i biciklični 3,4-dihidropirimidini kao inhibitori ćelijske proliferacije
SE0203754D0 (sv) New compounds
TW200510440A (en) Novel compounds
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
AU6581990A (en) New 1,2-benzisoxazole derivatives, processes for preparing them and pharmaceutical compositions containing them
ES8801247A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
TR200400541T4 (tr) Terapide faydalı tropan türevleri.
FI942635A0 (fi) Piperatsiinijohdannaiset 5HT1A-antagonisteina
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
FI962155A0 (fi) Uudet 9-hydroksipyrido (1,2-a) pyrimidin-4-onieetterijohdannaiset
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
HUP0303568A2 (hu) Benzotiofénszármazékok, eljárás előállításukra és alkalmazásuk
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
PL361282A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
AR028475A1 (es) Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
KR860001791A (ko) 질소함유 헤테로 사이클릭 화합물의 제법
ATE388945T1 (de) Benzoxazolderivate und deren verwendung als adenosinrezeptorliganden
ES2103590T3 (es) Derivados del acido 3-(indol-3-il) propenoico utilizables como antagonistas nmda.
DE50013571D1 (de) Arzneimittel zur behandlung von neuropathien

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1546134

Country of ref document: EP